首頁 > 市場調查報告書 > 製藥

骨疾病

歐洲骨關節炎治療市場預測至 2030 年 - 區域分析 - 按治療類型、疾病適應症和最終用戶

市場調查報告書

商品編碼

1562205

歐洲骨關節炎治療市場預測至 2030 年 - 區域分析 - 按治療類型、疾病適應症和最終用戶

Europe Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 108 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年歐洲骨關節炎治療市值為49.7151億美元，預計2030年將達到87.4393億美元；預計2022年至2030年複合年成長率為7.3%。

再生醫學的可用性推動歐洲骨關節炎治療市場

再生醫學是治療 OA 的傳統療法的一種新的、具有潛在變革性的替代方案。再生醫學利用生物醫學工程、生物材料和針對人體免疫系統的細胞療法來治療骨關節炎。此外，臨床研究人員也開發了使用患者（自體）細胞修復患者關節軟骨的方法。此外，再生療法選擇使用「基質誘導自體軟骨細胞植入（MACI）」。 MACI 可以修復小面積的軟骨，最後預防或延後 OA。此外，一些製造商正在開發專注於再生療法的產品。對 PRP 療法、幹細胞療法、透明質酸注射和增殖療法等非手術方法的日益青睞將推動再生醫學的採用。患有 OA 的患者可以使用非藥物療法進行治療。再生療法可以透過最終減輕骨關節炎患者的疼痛並提高整體生活品質來改善關節功能。因此，再生醫學的日益普及預計將在預測期內為骨關節炎治療市場帶來新的商機。

歐洲骨關節炎治療市場概況

歐洲骨關節炎治療市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。該地區骨關節炎治療藥物的快速產品批准和先進的醫療基礎設施是市場成長的最有影響力的因素。根據《健康監測雜誌》報道，骨關節炎是德國最常見的關節疾病。關節疼痛和功能喪失可能會導致生活品質下降，因為骨關節炎是由上肢（手指、手和肩膀）引起的。因此，隨著德國人口老化，骨關節炎盛行率將持續上升，對醫療保健系統造成沉重負擔。根據世界衛生組織（WHO）2020年發布的報告，德國骨關節炎死亡人數佔總死亡人數的0.05%。此外，新產品的推出促進了市場成長。例如，2023年5月，格倫泰宣布其研究性非鴉片類藥物「樹脂毒素（RTX）」獲得批准，該藥物目前正在進行臨床3期開發，並被美國食品和藥物管理局（USFDA）視為治療膝骨關節炎的突破性療法。樹脂毒素可以是一種有意義的非鴉片類藥物治療選擇，提供持久的疼痛緩解和受影響關節的功能改善。

歐洲骨關節炎治療市場收入及 2030 年預測（百萬美元）

歐洲骨關節炎治療市場區隔

歐洲骨關節炎治療市場按治療類型、疾病適應症、最終用戶和國家分類。

依治療類型，歐洲骨關節炎治療市場分為經皮神經電刺激（TENS）、職能治療、物理治療、富血小板血漿（PRP）治療及基質血管成分、增生療法等。 2022 年，物理治療領域佔據最大的市場。

從疾病適應症來看，歐洲骨關節炎治療市場細分為膝骨關節炎、脊椎骨關節炎、足踝骨關節炎、肩骨關節炎、手骨關節炎等。到 2022 年，膝骨關節炎細分市場將佔據歐洲骨關節炎治療市場的最大佔有率。

根據最終用戶，歐洲骨關節炎治療市場分為醫院和診所、專科診所、門診手術中心、家庭護理等。 2022 年，家庭護理領域佔據歐洲骨關節炎治療市場的最大佔有率。

依國家/地區分類，歐洲骨關節炎治療市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲骨關節炎治療市場佔有率中佔據主導地位。

Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc 和 Medi GmbH & Co KG 是歐洲骨關節炎治療市場上的一些領先公司。

Regenerative medicine is a new and potentially transformative alternative to traditional therapy options to treat OA. Regenerative medicine utilizes biomedical engineering, biomaterials, and cell therapies that target the body's immune system to treat OA. Also, clinical researchers have developed methods to fix the articular cartilage of patients using patients' (autologous) cells. Further, regenerative therapy options use "Matrix-Induced Autologous Chondrocyte Implantation (MACI)." MACI can repair small areas of cartilage, ultimately preventing or postponing OA. Also, several manufacturers are developing products focused on regenerative therapy. Rising inclination toward non-surgical approaches such as PRP therapy, stem cell therapy, hyaluronic acid injections, and prolotherapy would propel the adoption of regenerative medicine. Patients suffering from OA can be treated using non-pharmacological therapies. Regenerative therapy options can improve joint functions by ultimately reducing pain and enhancing the overall quality of life for individuals suffering from OA. Therefore, increasing adoption of regenerative medicine is expected to open new business opportunities in the osteoarthritis therapy market during the forecast period.

Europe Osteoarthritis Therapy Market Overview

Europe osteoarthritis therapy market is segmented as Germany, the UK, France, Italy, Spain, and the Rest of Europe. Fast product approvals in the region for osteoarthritis treatment drugs and advanced healthcare infrastructure are the most influential factors responsible for market growth. According to the Journal of Health Monitoring report, osteoarthritis is the most common joint disease in Germany. Joint pain and loss of function are likely to result in loss of quality of life as osteoarthritis is caused in the upper extremities (fingers, hands, and shoulders). Therefore, with the aging of Germany's population, osteoarthritis prevalence will continue to rise, resulting in a high burden on the healthcare system. According to the World Health Organization (WHO) report published in 2020, osteoarthritis deaths in Germany account for 0.05% of total deaths. Further, new product launches enhance the market growth. For instance, in May 2023, Grunenthal announced receiving approval for investigational non-opioid medicine "Resiniferatoxin (RTX)," currently undergoing Clinical Phase 3 development standing as a breakthrough therapy by the US Food and Drug Administration (USFDA) to treat knee OA. Resiniferatoxin can become a meaningful non-opioid treatment option, providing long-lasting pain relief and functional improvement of the affected joint.

Europe Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Europe Osteoarthritis Therapy Market Segmentation

The Europe osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Europe osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Europe osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Europe osteoarthritis therapy market in 2022.

Based on end users, the Europe osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Europe osteoarthritis therapy market in 2022.

By country, the Europe osteoarthritis therapy market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe osteoarthritis therapy market share in 2022.

Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, and Medi GmbH & Co KG are some of the leading companies operating in the Europe osteoarthritis therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis
- 4.1.1 Clinical Trial Pipeline Analysis

5. Europe Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Osteoarthritis
- 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
- 5.2.1 Product Recall
5.3 Market Opportunities
- 5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
- 5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Europe Market Analysis

6.1 Overview
- 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Europe Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Osteoarthritis Therapy Market - Country Analysis

10.1 Europe Market Overview
- 10.1.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
- 11.3.1 Overview
11.1 Inorganic Developments
- 11.1.1 Overview

12. Company Profiles

12.1 Zimmer Biomet Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 DePuy Synthes Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bioventus Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Omron Healthcare Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Exactech Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medi GmbH & Co KG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About the Insight Partners

簡介目錄圖表

List Of Tables

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 16. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 17. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 19. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 20. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies

List Of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)
Figure 26. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Growth Strategies in the Osteoarthritis Therapy market